Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results
– Conference Call and Webcast Today, August 4, 2022 at 4:30 p.m. ET PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal third quarter ended June 30, 2022. The company is hosting a conference call today, August 4, 2022, at 4:30 p.m. ET to discuss the results. Conference Call and … [Read more…]